These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 37738970)

  • 21. Tracking SARS-CoV-2 Omicron diverse spike gene mutations identifies multiple inter-variant recombination events.
    Ou J; Lan W; Wu X; Zhao T; Duan B; Yang P; Ren Y; Quan L; Zhao W; Seto D; Chodosh J; Luo Z; Wu J; Zhang Q
    Signal Transduct Target Ther; 2022 Apr; 7(1):138. PubMed ID: 35474215
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SARS-CoV-2 ORF6 Disrupts Bidirectional Nucleocytoplasmic Transport through Interactions with Rae1 and Nup98.
    Addetia A; Lieberman NAP; Phung Q; Hsiang TY; Xie H; Roychoudhury P; Shrestha L; Loprieno MA; Huang ML; Gale M; Jerome KR; Greninger AL
    mBio; 2021 Apr; 12(2):. PubMed ID: 33849972
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Computational analysis of affinity dynamics between the variants of SARS-CoV-2 spike protein (RBD) and human ACE-2 receptor.
    Sultana N; Nagesha SN; Reddy CNL; Ramesh BN; Shyamalamma S; Shashidhara KS; Satish KM; Pradeep C; Vidyadhar GD
    Virol J; 2024 Apr; 21(1):88. PubMed ID: 38641844
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SARS-CoV-2 Omicron subvariants progressively adapt to human cells with altered host cell entry.
    Sakurai Y; Okada S; Ozeki T; Yoshikawa R; Kinoshita T; Yasuda J
    mSphere; 2024 Sep; 9(9):e0033824. PubMed ID: 39191389
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Host-Genome Similarity Characterizes the Adaption of SARS-CoV-2 to Humans.
    Sun W
    Biomolecules; 2022 Jul; 12(7):. PubMed ID: 35883528
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SARS-CoV-2 Variants Show Different Host Cell Proteome Profiles With Delayed Immune Response Activation in Omicron-Infected Cells.
    Metzler M; Tharyan RG; Klann K; Grikscheit K; Bojkova D; Cinatl J; Tascher G; Ciesek S; Münch C
    Mol Cell Proteomics; 2023 May; 22(5):100537. PubMed ID: 37001587
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of SARS-CoV-2 ORF6 and its variant polymorphisms on host responses and viral pathogenesis.
    Kehrer T; Cupic A; Ye C; Yildiz S; Bouhhadou M; Crossland NA; Barrall E; Cohen P; Tseng A; Çağatay T; Rathnasinghe R; Flores D; Jangra S; Alam F; Mena N; Aslam S; Saqi A; Marin A; Rutkowska M; Ummadi MR; Pisanelli G; Richardson RB; Veit EC; Fabius JM; Soucheray M; Polacco BJ; Evans MJ; Swaney DL; Gonzalez-Reiche AS; Sordillo EM; van Bakel H; Simon V; Zuliani-Alvarez L; Fontoura BMA; Rosenberg BR; Krogan NJ; Martinez-Sobrido L; García-Sastre A; Miorin L
    bioRxiv; 2022 Nov; ():. PubMed ID: 36299428
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of SARS-CoV-2 variants of concern in primary human nasal cultures demonstrates Delta as most cytopathic and Omicron as fastest replicating.
    Tanneti NS; Patel AK; Tan LH; Marques AD; Perera RAPM; Sherrill-Mix S; Kelly BJ; Renner DM; Collman RG; Rodino K; Lee C; Bushman FD; Cohen NA; Weiss SR
    mBio; 2024 Apr; 15(4):e0312923. PubMed ID: 38477472
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selective adaptation of SARS-CoV-2 Omicron under booster vaccine pressure: a multicentre observational study.
    Duerr R; Dimartino D; Marier C; Zappile P; Wang G; François F; Ortigoza MB; Iturrate E; Samanovic MI; Mulligan MJ; Heguy A
    EBioMedicine; 2023 Nov; 97():104843. PubMed ID: 37866115
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SARS-CoV-2 variant biology and immune evasion.
    Zaidi AK; Singh RB
    Prog Mol Biol Transl Sci; 2024; 202():45-66. PubMed ID: 38237990
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Unraveling the Dynamics of Omicron (BA.1, BA.2, and BA.5) Waves and Emergence of the Deltacton Variant: Genomic Epidemiology of the SARS-CoV-2 Epidemic in Cyprus (Oct 2021-Oct 2022).
    Chrysostomou AC; Vrancken B; Haralambous C; Alexandrou M; Gregoriou I; Ioannides M; Ioannou C; Kalakouta O; Karagiannis C; Marcou M; Masia C; Mendris M; Papastergiou P; Patsalis PC; Pieridou D; Shammas C; Stylianou DC; Zinieri B; Lemey P; The Comessar Network ; Kostrikis LG
    Viruses; 2023 Sep; 15(9):. PubMed ID: 37766339
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structural Basis for the Enhanced Infectivity and Immune Evasion of Omicron Subvariants.
    Li Y; Shen Y; Zhang Y; Yan R
    Viruses; 2023 Jun; 15(6):. PubMed ID: 37376697
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The outbreak of SARS-CoV-2 Omicron lineages, immune escape, and vaccine effectivity.
    Zhou Y; Zhi H; Teng Y
    J Med Virol; 2023 Jan; 95(1):e28138. PubMed ID: 36097349
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adaptive variations in SARS-CoV-2 spike proteins: effects on distinct virus-cell entry stages.
    Qing E; Gallagher T
    mBio; 2023 Aug; 14(4):e0017123. PubMed ID: 37382441
    [TBL] [Abstract][Full Text] [Related]  

  • 35. AlphaFold2-Enabled Atomistic Modeling of Structure, Conformational Ensembles, and Binding Energetics of the SARS-CoV-2 Omicron BA.2.86 Spike Protein with ACE2 Host Receptor and Antibodies: Compensatory Functional Effects of Binding Hotspots in Modulating Mechanisms of Receptor Binding and Immune Escape.
    Raisinghani N; Alshahrani M; Gupta G; Xiao S; Tao P; Verkhivker G
    J Chem Inf Model; 2024 Mar; 64(5):1657-1681. PubMed ID: 38373700
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The significant immune escape of pseudotyped SARS-CoV-2 variant Omicron.
    Zhang L; Li Q; Liang Z; Li T; Liu S; Cui Q; Nie J; Wu Q; Qu X; Huang W; Wang Y
    Emerg Microbes Infect; 2022 Dec; 11(1):1-5. PubMed ID: 34890524
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Omicron: What Makes the Latest SARS-CoV-2 Variant of Concern So Concerning?
    Jung C; Kmiec D; Koepke L; Zech F; Jacob T; Sparrer KMJ; Kirchhoff F
    J Virol; 2022 Mar; 96(6):e0207721. PubMed ID: 35225672
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SARS-CoV-2 Variants of Concern Hijack IFITM2 for Efficient Replication in Human Lung Cells.
    Nchioua R; Schundner A; Kmiec D; Prelli Bozzo C; Zech F; Koepke L; Graf A; Krebs S; Blum H; Frick M; Sparrer KMJ; Kirchhoff F
    J Virol; 2022 Jun; 96(11):e0059422. PubMed ID: 35543509
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of Spike Mutations in SARS-CoV-2 Variants of Concern on Human or Animal ACE2-Mediated Virus Entry and Neutralization.
    Kim Y; Gaudreault NN; Meekins DA; Perera KD; Bold D; Trujillo JD; Morozov I; McDowell CD; Chang KO; Richt JA
    Microbiol Spectr; 2022 Jun; 10(3):e0178921. PubMed ID: 35638818
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhanced neutralization resistance of SARS-CoV-2 Omicron subvariants BQ.1, BQ.1.1, BA.4.6, BF.7, and BA.2.75.2.
    Qu P; Evans JP; Faraone JN; Zheng YM; Carlin C; Anghelina M; Stevens P; Fernandez S; Jones D; Lozanski G; Panchal A; Saif LJ; Oltz EM; Xu K; Gumina RJ; Liu SL
    Cell Host Microbe; 2023 Jan; 31(1):9-17.e3. PubMed ID: 36476380
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.